NovaSonix Healthcare Inc. strives to develop cutting-edge ultrasound technology to improve clinical practice for the prevention, detection, and monitoring of musculoskeletal disease. Our system, NovaVue, is compatible with any commercially available ultrasound machine, and collects 3D and dynamic ultrasound images of any joint, providing clinicians with a comprehensive, inexpensive, and non-invasive tool that fits seamlessly into current workflows to diagnose and monitor musculoskeletal pathologies such as osteoarthritis.

Revolutionizing musculoskeletal ultrasound to deliver effective, efficient, and comprehensive patient care.

With a global aging population, musculoskeletal conditions, such as osteoarthritis, are on the rise, pointing to a dire need for accessible and effective point-of-care imaging to accommodate the rising number of patients. At NovaSonix Healthcare, we strive to improve the early detection of osteoarthritis to allow patients quicker access to early interventions that can delay the progression of the disease and improve their quality of life.

Our cutting-edge technology backed by academic research at Robarts Research Institute, one of Canada’s leading research centers in the development and implementation of technologies in advanced imaging.

At NovaSonix Healthcare, we have access to well-established research facilities for the testing of our devices along with software developers, research staff and coordinators. We have an exceptional advisory committee of physician experts in osteoarthritis, rheumatoid arthritis, and orthopedic surgery to ensure the development of clinically relevant solutions.